Research Peptides for Cognitive Research
Quick Answer
The honest answer first: Peptide.Express does not stock nootropic peptides. Semax, Selank and Dihexa — the compounds with an actual memory- and learning-endpoint literature — are not in this catalogue, and no compound that is has published data on cognitive performance. What the catalogue does hold are two central nervous system receptor tools. PT-141 is a cyclic heptapeptide agonist at hypothalamic MC3R and MC4R. Kisspeptin-10 is a GPR54 agonist acting on GnRH neurons. Both are CNS pharmacology. Neither is a cognition compound, and calling one would be wrong.
Overview
Central nervous system signalling and cognition are not the same subject, and collapsing them is how vendor pages end up recommending a melanocortin agonist for memory. PT-141 is used in hypothalamic circuit work precisely because it has no meaningful activity on vascular smooth muscle — it is the CNS-side reference compound when a PDE5 inhibitor supplies the peripheral arm. Kisspeptin-10 is studied with patch-clamp recording of GnRH neuron firing, which is neuronal electrophysiology in the strict sense and reproductive neuroendocrinology in subject matter. If the endpoint is memory, attention or learning, nothing in this catalogue is the right tool. That is a shorter list than most sites publish against this query, and it is the accurate one.
Recommended Peptides for Cognitive Research
PT-141 (Bremelanotide)
A cyclic heptapeptide agonist at MC3R and MC4R, both centrally distributed — MC4R densely in the paraventricular nucleus and medial preoptic area, MC3R in the arcuate nucleus and limbic structures. It is the standard tool for separating central from peripheral mechanism, since it does not act on vascular smooth muscle. It has not been studied against cognitive endpoints.
Kisspeptin-10
A decapeptide GPR54/KISS1R agonist that couples through Gq rather than Gs, which is unusual among the neuroendocrine compounds here. The research use is GnRH neuron electrophysiology and LH pulse-generator work. GPR54 desensitises under continuous exposure, so bolus and infusion designs can read out in opposite directions on the same endpoint.
Frequently Asked Questions
What peptides are studied for cognitive research?
The nootropic peptide literature centres on Semax, Selank and Dihexa, with memory, learning and neurotrophic endpoints. None of those is stocked by Peptide.Express. Anyone building a cognition protocol should source from that group rather than from the compounds listed on this page, which are neuroendocrine tools.
Are PT-141 or Kisspeptin-10 nootropics?
No. Both act in the central nervous system, which is a different claim entirely. PT-141 is a melanocortin agonist studied in hypothalamic circuit and feeding-pathway models; Kisspeptin-10 is a GPR54 agonist studied in the hypothalamic-pituitary-gonadal axis. Neither has published memory, attention or learning data behind it.
Does any compound in this catalogue have cognitive-endpoint data?
None that we can point to a source for. Several compounds cross into the central nervous system — DSIP is used as a reference compound in blood-brain barrier transport research — but crossing the barrier is a pharmacokinetic property, not a cognitive effect. We would rather publish that gap than manufacture a rationale to fill it.
What is the difference between PT-141 and Melanotan II?
One functional group. Melanotan II ends in a carboxamide, PT-141 in a free acid, and the mass gap is about 1 Da. That single change shifted receptor selectivity enough to send the two molecules down separate paths — PT-141 lost most of the MC1R and MC5R activity Melanotan II retains, which is why the pair is used for selectivity attribution.
Are these compounds purity-verified?
Yes. PT-141 and Kisspeptin-10 are HPLC-verified at ≥99% purity with LC-MS/MS mass confirmation and a batch-specific Certificate of Analysis. For Kisspeptin-10, the C-terminal amide is the specification to check on the CoA — remove it and receptor binding at GPR54 falls off sharply.
References
- Molinoff PB, Shadiack AM, Earle D, Diamond LE, Quon CY. PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann N Y Acad Sci. 2003. Read Molinoff et al. on PT-141 as an MC3R/MC4R melanocortin agonist
- Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol. 1994. Read Mountjoy et al. on MC4R distribution in hypothalamic and autonomic circuits
- Vyleesi (bremelanotide) injection, FDA-approved prescribing information via DailyMed. Bremelanotide is approved for hypoactive sexual desire disorder in premenopausal women; the approval covers the finished drug product only. Read the Vyleesi (bremelanotide) FDA prescribing information
- Han SK, Gottsch ML, Lee KJ, Popa SM, Smith JT, Jakawich SK, Clifton DK, Steiner RA, Herbison AE. Activation of gonadotropin-releasing hormone neurons by kisspeptin as a neuroendocrine switch for the onset of puberty. J Neurosci. 2005. Read Han et al. on kisspeptin-evoked depolarization of GnRH neurons
- de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A. 2003. Read de Roux et al.'s identification of GPR54 loss-of-function hypogonadotropic hypogonadism
- Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst. 1996. Read Lee et al.'s identification of KiSS-1 as a melanoma metastasis suppressor
Explore More Research Areas
Browse All Research Peptides
Explore our complete catalog of HPLC-verified research peptides. Every product includes a Certificate of Analysis documenting purity and identity. Same-day US shipping on orders before 2 PM EST. For in-vitro laboratory research use only.
Browse CatalogHow This Page Is Sourced
Compiled by the Peptide.Express Research Team. Reviewed by Ben Laythee, Lead Chemist. Molecular identity on this page — name, CAS number, molecular formula and molecular weight — is resolved from a single internal entity record and checked against primary registries (PubChem, CAS Common Chemistry) rather than retyped per page. A field with no verified value is left out instead of estimated. Literature is cited to a DOI, PMID or PMCID permalink so every reference resolves to the specific record it names.